To demonstrate that tumor gene reprogramming promoted by EGF and PGE2-induced nuclear EGFR is critical for tumor progression, we have assessed cell proliferation by BrdU incorporation assay in NSCLC cells. This evidence concerns the gene EGF and neoplasm.